3,5-di-tert-butyl-4-hydroxybenzoic acid

Also Known As:

3,5-di-tert-butyl-4-hydroxybenzoic acid, monopotassium salt; 3,5-di-tert-butyl-4-hydroxybenzoic acid, monosodium salt; 3,5-di-tert-butyl-4-hydroxybenzoic acid, nickel (2+) salt (2:1); BHT-COOH

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

Infertility (Sterility)

01/01/2023 - "Compared with the low levels of BHT metabolites, the adjusted odds ratios (ORs) for DOR were significantly increased in the high levels of BHT-CHO [OR=3.19, 95% confidence interval (CI): 1.22, 8.31, p=0.018], BHT-COOH [OR=4.73 (95% CI: 1.63, 13.71), p=0.004], and BHT-Q [OR=4.48 (95% CI: 1.69, 11.86), p=0.003] after adjusting for age, body mass index, education, infertility type, triglycerides, and total cholesterol. "

Related Drugs and Biologics

1.	Triglycerides (Triacylglycerol)
2.	Cholesterol
3.	Butylated Hydroxytoluene (BHT)
4.	3,5-di-tert-butyl-4-hydroxybenzaldehyde
5.	ORALIT (ORS)